⌘K

Login Start Free

Home/Filings/4/0001193125-25-303941

4//SEC Filing

Goldan Keith A. 4

Accession 0001193125-25-303941

CIK 0001395937other

View on SEC.gov Company Profile

Filed

Nov 30, 7:00 PM ET

Accepted

Dec 1, 4:30 PM ET

Size

4.4 KB

Accession

0001193125-25-303941

Insider Transaction Report

Form 4

Period: 2025-12-01

Syndax Pharmaceuticals IncSNDX

Goldan Keith A.

Chief Financial Officer

Transactions

Gift
Common Stock
2025-12-01−1,224→ 92,452 total

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Syndax Pharmaceuticals Inc

CIK 0001395937

Entity typeother

Related Parties

1

filerCIK 0001495411

Filing Metadata

Form type: 4
Filed: Nov 30, 7:00 PM ET
Accepted: Dec 1, 4:30 PM ET
Size: 4.4 KB

View on SEC.gov